@RNAiAnalyst

rnaianalyst.bsky.social

10 June 2025 00:26

MAHA Vows to Disrupt Sick-Care Model in Favor of Cures (blog): rnaitherapeutics.blogspot.com/2025/06/maha... #CRISPR #cures #genetherapy #FDA $NTLA $VERV $BBIO 💊

@RNAiAnalyst

rnaianalyst.bsky.social

04 June 2025 07:17

#ProQR votes are out. deBoer (86.3%) + Shannon (80.7%) re-appointed as Directors. Should encourage corp governance discussion. Only 78.5% of votes cast were in favor of authorizing Board to issue shares. Not sure the 'no' are aware that we are in the biotech business? www.sec.gov/Archives/edg...

@RNAiAnalyst

rnaianalyst.bsky.social

02 June 2025 16:20

#RNAi Therapeutics A Bright Spot In Dark Biotech Winter (blog): rnaitherapeutics.blogspot.com/2025/06/rnai... $ALNY $ARWR $SLN $RGLS $QURE

@RNAiAnalyst

rnaianalyst.bsky.social

01 June 2025 14:06

#ANGPTL3 it may be time for #ArrowheadTherapeutics and #VerveTherapeutics to reposition their ANGPTL3-targeting agents from currently only homoFH and potentially ASCVD...to much larger #MASH opportunity. See also #EliLilly's solbinsiran and Arrowhead's zodasiran ANGPTL3 results:

@RNAiAnalyst

rnaianalyst.bsky.social

01 June 2025 14:05

#RNAi pure-plays #Alnylam and #SilenceTherapeutics continue moving higher. Alnylam soon worth more than #Regeneron. Oligos still much less #China exposure compared to antibodies and CAR-Ts. Me-thinks we'll see eye-cathing M&A soon.